The Trump administration wants to bring the production of more drugs, including medicines like antibiotics that may be in short supply, closer to the patient — including inside the hospital. The partnership between some of the nation's top health agencies and a handful of companies, including the Mark Cuban Cost Plus Drug Company, is intended to use artificial intelligence and other tools to make eight drugs in the places where people actually get medical care.
